0
Chest Infections: Tuberculosis |

Treatment Response and Adverse Drug Events in Rifampicin Resistant TB Patients on Second Line Anti-Tubercular Treatment in a Tertiary Care Center of Western India

Mani Tiwari, MBBS; Mahendra Patel, MD
Author and Funding Information

Government Medical College, Surat, India


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):207A. doi:10.1016/j.chest.2016.08.216
Text Size: A A A
Published online

Extract

SESSION TITLE: Tuberculosis

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM

PURPOSE: This study was done to know the bacteriological and radiological response of second line ATT (Category IV regimen), Adverse drug reactions (ADR) and Death and default rates during one year of treatment.

METHODS: Retrospective study was carried out in a tertiary care center of Western India, 308 confirmed Drug Resistant TB patients diagnosed by CBNAAT were enrolled under RNTCP Category IV (MDR-TB) regimen. Bacteriological follow up was done as per RNTCP schedule and Chest X-rays done at baseline, 6 months and 12 months were taken into consideration to evaluate the response to treatment. ADR during this period were vigilantly documented.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543